Back to today’s briefing

Story perspectives

U.S. Firms Seek FDA Approval for Noninvasive Endometriosis Tests

9/5/2026

12 1 Full Breakdown

Summary

Story summary

U.S. firms are applying to the FDA for approval of new non-invasive endometriosis tests.
Endotest analyzes saliva for microRNAs and provides results in two to three weeks.
The UK health institute drafted three-year guidance to use both tests in primary care.
French firm Ziwig plans to offer Endotest via certified labs without FDA clearance.
Experts warn that normalizing period pain still delays diagnosis for an estimated 190 million women worldwide.

1 of 1

Story summary

U.S. firms are applying to the FDA for approval of new non-invasive endometriosis tests.
Endotest analyzes saliva for microRNAs and provides results in two to three weeks.
The UK health institute drafted three-year guidance to use both tests in primary care.
French firm Ziwig plans to offer Endotest via certified labs without FDA clearance.
Experts warn that normalizing period pain still delays diagnosis for an estimated 190 million women worldwide.